Joy Wolfram: Nanoparticles, fire trucks, and changing our approach to cancer
Published on: 16 June 2023
Nanomedicine on the development of new strategies for the treatment of disease
Associate Professor Joy Wolfram’s research program in nanomedicine on the development of new strategies for the treatment of disease. In particular, her team is developing extracellular vesicle therapeutics and diagnostics for inflammatory conditions and cancer.
Nanotechnology enables the design of multifunctional and targeted strategies, thereby increasing therapeutic efficacy and reducing side effects. The ultimate goal of the research program is to bring new nanomedicines to clinical practice.
The research program has three main focus areas:
- Developing improved methods for extracellular vesicle isolation from human biofluids;
- Designing hybrid drug delivery systems with extracellular vesicle and synthetic components for a 'best-of-both-worlds' approach to treat inflammatory conditions, and;
- Understanding the role of extracellular vesicles in breast cancer metastasis.
